PTH and medullary thyroid gland carcinoma: Increased cabozantinib clearance in MTC patients at steady state could be related to treatment-emergent hypocalcemia, particularly in advanced MTC patients who undergo thyroidectomy when the parathyroid glands are also partially or completely removed resulting in decreased plasma parathyroid hormone levels.